Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 1  Agents affecting nervous system and sensory organs
   11  Agents affecting central nervous system
   12  Agents affecting peripheral nervous system
   13  Agents affecting sensory organs
     131  Ophthalmic agents
       1311  Mydriatic agents
       1312  Miotic agents
       1313  Ophthalmic local anesthetics
       1314  Ophthalmic aseptic astringents
       1315  Ophthalmic cortisones
       1316  Ophthalmic local vasoconstrictors
       1317  Ophthalmic antibiotics
       1318  Alkaloids
       1319  Others
         D00983  Triamcinolone acetonide (JP18/USP)
         D01121  Rebamipide (JP18/INN)
         D00526  Cromolyn sodium (USP); Sodium cromoglicate (JP18)
         D00166  Cyanocobalamin (JP18/USP/INN)
         D00603  Timolol maleate (JP18/USP)
         D00599  Carteolol hydrochloride (JP18/USP)
         D00598  Betaxolol hydrochloride (JP18/USP)
         D03354  Hyaluronate sodium (USAN); Purified sodium hyaluronate (JP18); Sodium hyaluronate (JAN)
         D00222  Acyclovir (USP); Aciclovir (JP18/INN)
         D04250  Fradiomycin sulfate and methylprednisolone
         D01730  Silver nitrate (JP18/USP)
         D00107  Tacrolimus (USP/INN); Tacrolimus hydrate (JP18)
         D00904  Diclofenac sodium (JP18/USP)
         D02076  Brimonidine tartrate (JAN/USAN)
         D00453  Ofloxacin (JP18/USP/INN)
         D00210  Norfloxacin (JP18/USP/INN)
         D00873  Lomefloxacin hydrochloride (JAN/USAN)
         D00588  Levofloxacin (USP); Levofloxacin hydrate (JP18)
         D00874  Moxifloxacin hydrochloride (JAN/USP)
         D00589  Gatifloxacin (USAN); Gatifloxacin hydrate (JP18)
         D01996  Tosufloxacin tosylate hydrate (JP18)
         D09574  Aflibercept (USAN/INN); Aflibercept (genetical recombination) (JAN); Aflibercept (genetical recombination) [Aflibercept biosimilar 1] (JAN)
         D00184  Cyclosporine (USP); Ciclosporin (JP18)
         D04078  Chondroitin sulfate sodium (JAN)
         D04114  Neostigmine methylsulfate and inorganic salt
         D01717  Levocabastine hydrochloride (JAN/USP)
         D01192  Olopatadine hydrochloride (JP18/USP)
         D01385  Ibudilast (JP18/INN)
         D01332  Ketotifen fumarate (JP18/USAN)
         D01713  Epinastine hydrochloride (JAN)
         D03243  Sodium borate (JP18/NF)
         D01578  Pranoprofen (JP18/INN)
         D05143  Nepafenac (JAN/USAN/INN)
         D03163  Bromfenac sodium (USAN); Bromfenac sodium hydrate (JP18)
         D04246  Fradiomycin sulfate and betamethasone sodium phosphate
         D01008  Apraclonidine hydrochloride (JAN/USP)
         D00653  Dorzolamide hydrochloride (JP18/USP)
         D00652  Brinzolamide (JAN/USP/INN)
         D10854  Brinzolamide and brimonidine tartrate
         D10512  Brinzolamide and timolol maleate
         D01025  Levobunolol hydrochloride (JAN/USP)
         D07505  Latanoprost and timolol maleate
         D08493  Dorzolamide hydrochloride and timolol maleate (JP18)
         D09815  Travoprost and timolol maleate
         D10298  Brimonidine tartrate and timolol maleate
         D10569  Tafluprost and timolol maleate
         D10804  Carteolol and latanoprost
         D00356  Latanoprost (JAN/USP/INN)
         D01452  Isopropyl unoprostone (JAN)
         D02724  Bimatoprost (JAN/USAN/INN)
         D01964  Travoprost (JAN/USP/INN)
         D06274  Tafluprost (JAN/USAN/INN)
         D10966  Omidenepag isopropyl (JAN)
         D10463  Ripasudil hydrochloride hydrate (JAN)
         D04081  Tropicamide and phenylephrine hydrochloride
         D07632  Chondroitin sulfate sodium and sodium hyaluronate
         D01162  Verteporfin (JAN/USP/INN)
         D05697  Ranibizumab (USAN/INN); Ranibizumab (genetical recombination) (JAN); Ranibizumab (genetical recombination) [Ranibizumab biosimilar 1] (JAN)
         D11083  Brolucizumab (USAN/INN); Brolucizumab (genetical recombination) (JAN)
         D11516  Faricimab (USAN/INN); Faricimab (genetical recombination) (JAN)
         D02706  Sodium gualenate hydrate (JAN)
         D04113  Boric acid and Inorganic salt
         D03635  Cysteamine hydrochloride (JAN/USAN)
         D01089  Boric acid (JP18/NF)
         D00014  Glutathione (JP18)
         D00031  Oxiglutatione (JAN/INN)
         D01031  Helenien (JAN); Xantofyl palmitate (INN)
         D01088  Pemirolast potassium (JP18/USAN)
         D01100  Pirenoxine (JP18/INN)
         D01691  Nipradilol (JAN/INN)
         D01887  Bunazosin hydrochloride (JP18)
         D02027  Tranilast (JP18/USAN/INN)
         D03233  Acitazanolast hydrate (JAN)
         D03864  Diquafosol tetrasodium (USAN); Diquafosol sodium (JAN)
         D04099  Erythromycin lactobionate and colistin sodium methanesulfonate
         D04106  Chloramphenicol and colistin sodium methanesulfonate (JP18)
         D04109  Glucose and inorganic salt
         D04285  Concentrated glycerin and fructose
         D07633  Chondroitin sulfate sodium and FAD sodium
         D07703  Hydroxyethyl cellulose, boric acid, dibasic sodium phosphate, potassium chloride, sodium chloride and dried sodium carbonate
         D07709  Polyvinyl alcohol and iodine
         D12437  Ripasudil hydrochloride and brimonidine tartrate
     132  Otic and nasal agents
     133  Vertigo agents
     139  Miscellaneous
   19  Other agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
   31  Vitamins
   32  Nutrients, tonics
   33  Blood and body fluid agents
   34  Dialysis agents
   39  Other agents affecting metabolism
     391  Liver disease agents
     392  Antidotes
       3921  EDTAs
       3922  Glutathiones
         D00014  Glutathione (JP18)
       3923  Mercaptoacetates
       3924  Taurines
       3925  Sodium thiosulfates
       3929  Others
     393  Habitual intoxication agents
     394  Gout preparations
     395  Enzyme preparations
     396  Antidiabetic agents
     397  Metabolic disease preparations & combinations
     399  Miscellaneous
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 19, 2024
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version